SOX9 in cartilage development and disease.


Journal

Current opinion in cell biology
ISSN: 1879-0410
Titre abrégé: Curr Opin Cell Biol
Pays: England
ID NLM: 8913428

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 06 2019
accepted: 06 07 2019
pubmed: 6 8 2019
medline: 15 4 2020
entrez: 6 8 2019
Statut: ppublish

Résumé

SOX9 is a pivotal transcription factor in chondrocytes, a lineage essential in skeletogenesis. Its mandatory role in transactivating many cartilage-specific genes is well established, whereas its pioneer role in lineage specification, which along with transactivation defines master transcription factors, remains to be better defined. Abundant, but yet incomplete evidence exists that intricate molecular networks control SOX9 activity during the multi-step chondrogenesis pathway. They include a highly modular genetic regulation, post-transcriptional and post-translational modifications, and varying sets of functional partners. Fully uncovering SOX9 actions and regulation is fundamental to explain mechanisms underlying many diseases that directly or indirectly affect SOX9 activities and to design effective disease treatments. We here review current knowledge, highlight recent discoveries, and propose new research directions to answer remaining questions.

Identifiants

pubmed: 31382142
pii: S0955-0674(19)30044-4
doi: 10.1016/j.ceb.2019.07.008
pmc: PMC6956855
mid: NIHMS1534366
pii:
doi:

Substances chimiques

SOX9 Transcription Factor 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-47

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR068308
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR072649
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Bone. 2019 Aug;125:169-177
pubmed: 31121357
Genes Dev. 2004 May 1;18(9):1072-87
pubmed: 15132997
Urology. 2012 Apr;79(4):908-11
pubmed: 21962881
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2882-7
pubmed: 23382206
Nat Genet. 2009 Mar;41(3):359-64
pubmed: 19234473
Nat Commun. 2011;2:251
pubmed: 21427722
J Biol Chem. 2003 Jul 18;278(29):27224-9
pubmed: 12732631
Biochem Biophys Res Commun. 2018 Feb 2;:null
pubmed: 29402405
Arthritis Rheum. 2004 Nov;50(11):3561-73
pubmed: 15529345
Science. 2018 Jun 29;360(6396):1469-1473
pubmed: 29903884
PLoS Genet. 2011 Nov;7(11):e1002356
pubmed: 22072985
Dev Cell. 2012 Mar 13;22(3):597-609
pubmed: 22421045
Bone Res. 2015 Aug 11;3:15021
pubmed: 26558140
Dev Cell. 2001 Aug;1(2):277-90
pubmed: 11702786
Development. 2018 Mar 16;145(6):
pubmed: 29511023
Sci Rep. 2019 May 21;9(1):7666
pubmed: 31113964
Hum Mol Genet. 2015 Mar 15;24(6):1764-73
pubmed: 25432534
Semin Cell Dev Biol. 2017 Feb;62:34-49
pubmed: 27771362
J Clin Invest. 2017 Apr 3;127(4):1475-1484
pubmed: 28263186
Nucleic Acids Res. 2013 Apr;41(8):4459-69
pubmed: 23449223
Nat Cell Biol. 2014 Dec;16(12):1157-67
pubmed: 25419849
Mol Cell Biol. 2000 Jun;20(11):4149-58
pubmed: 10805756
Dev Biol. 2018 Feb 1;434(1):186-195
pubmed: 29273440
J Biol Chem. 1999 Aug 20;274(34):24023-30
pubmed: 10446171
Dev Biol. 2006 Mar 15;291(2):382-97
pubmed: 16458883
BMC Genomics. 2018 Jun 19;19(1):481
pubmed: 29921221
Bone Res. 2018 Apr 6;6:12
pubmed: 29644115
Development. 2013 Oct;140(20):4129-44
pubmed: 24086078
Nucleic Acids Res. 2019 Jul 26;47(13):6917-6931
pubmed: 31194875
Nat Genet. 1996 Jun;13(2):230-2
pubmed: 8640233
Dev Cell. 2018 Sep 24;46(6):794-806.e6
pubmed: 30146478
Nature. 2016 Oct 13;538(7624):265-269
pubmed: 27706140
Curr Top Dev Biol. 2019;133:119-151
pubmed: 30902250
Genes Dev. 2002 Nov 1;16(21):2813-28
pubmed: 12414734
Curr Top Dev Biol. 2019;133:171-193
pubmed: 30902252
PLoS Genet. 2017 Feb 6;13(2):e1006610
pubmed: 28166224
Sci Rep. 2015 May 27;5:10398
pubmed: 26013289
Cell Rep. 2015 Jul 14;12(2):229-43
pubmed: 26146088
Development. 2015 Mar 1;142(5):817-31
pubmed: 25715393
Nucleic Acids Res. 2015 Sep 30;43(17):8183-203
pubmed: 26150426
Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14665-70
pubmed: 16203988
Matrix Biol. 2005 Jan;23(8):499-505
pubmed: 15694126
Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):160-5
pubmed: 11120880
Curr Top Dev Biol. 2019;133:343-385
pubmed: 30902258
Development. 2011 Apr;138(8):1507-19
pubmed: 21367821
Semin Cell Dev Biol. 2017 Feb;62:3-15
pubmed: 27418125
Cell. 1994 Dec 16;79(6):1111-20
pubmed: 8001137
PLoS Genet. 2018 Apr 16;14(4):e1007346
pubmed: 29659575
Cell. 1998 Jun 12;93(6):985-96
pubmed: 9635428
Development. 2018 Jun 26;145(12):
pubmed: 29777011
Development. 2017 Dec 15;144(24):4510-4521
pubmed: 29084806
J Cell Biol. 2004 Mar 1;164(5):747-58
pubmed: 14993235
Nucleic Acids Res. 2015 Jun 23;43(11):5394-408
pubmed: 25940622
Development. 2016 Aug 15;143(16):3012-23
pubmed: 27471255
Connect Tissue Res. 2017 Jan;58(1):2-14
pubmed: 27128146
J Cell Physiol. 2008 Oct;217(1):228-41
pubmed: 18506848
Curr Rheumatol Rep. 2016 Jul;18(7):43
pubmed: 27289467
Aging Cell. 2016 Jun;15(3):499-508
pubmed: 26910618
Development. 2018 Jul 18;145(14):
pubmed: 30021842
Development. 2007 Nov;134(21):3917-28
pubmed: 17913788
Mol Genet Genomic Med. 2015 Jul 14;3(6):550-7
pubmed: 26740947
Dev Biol. 2015 Feb 15;398(2):242-54
pubmed: 25527076
Nature. 1994 Dec 8;372(6506):525-30
pubmed: 7990924
Development. 2007 Sep;134(18):3271-81
pubmed: 17699610

Auteurs

Véronique Lefebvre (V)

Department of Surgery/Division of Orthopedic Surgery, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, United States. Electronic address: lefebvrev1@email.chop.edu.

Marco Angelozzi (M)

Department of Surgery/Division of Orthopedic Surgery, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, United States.

Abdul Haseeb (A)

Department of Surgery/Division of Orthopedic Surgery, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH